Carolyn S Grove
6PUBLICATIONS
44CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|May 07, 2025
Menin inhibition with revumenib for NPM1-mutated relapsed or refractory acute myeloid leukemia: the AUGMENT-101 study.Martha L Arellano, Michael J Thirman, John F DiPersio
|Aug 09, 2024
Menin Inhibition With Revumenib for KMT2A-Rearranged Relapsed or Refractory Acute Leukemia (AUGMENT-101).Ghayas C Issa, Ibrahim Aldoss, Michael J Thirman
|Aug 05, 2024
Asciminib monotherapy as frontline treatment of chronic-phase chronic myeloid leukemia: results from the ASCEND study.David T Yeung, Naranie Shanmuganathan, John Reynolds
|Feb 01, 2023
Olutasidenib (FT-2102) induces durable complete remissions in patients with relapsed or refractory IDH1-mutated AML.Stéphane de Botton, Pierre Fenaux, Karen Yee
|Sep 23, 2021
Clinical impact of NPM1-mutant molecular persistence after chemotherapy for acute myeloid leukemia.Ing S Tiong, Richard Dillon, Adam Ivey
|Aug 11, 2017
Preventing chemotherapy-induced myelosuppression by repurposing the FLT3 inhibitor quizartinib.Samuel J Taylor, Johanna M Duyvestyn, Samantha A Dagger
Pageof 1
Frequent Collaborators
2 joint publications
Stéphane de Botton
2 joint publications
Andrew H Wei
2 joint publications
Pau Montesinos
2 joint publications
Alexander Perl
2 joint publications
Elie Traer
2 joint publications
David S Dickens
2 joint publications
James S Blachly
2 joint publications
Ghayas C Issa
1 joint publications
Karen Yee
1 joint publications
Christian Récher
